Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Sionna Therapeutics, Inc. , a clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF).

52W Range

4thpctl

Volume

0.57×avg

Market Cap

265.03MUSD

P/E Ratio

-2.7TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Sionna Therapeutics, Inc.

SIONNASDAQ Global Market·USD·Closed

Sionna Therapeutics, Inc.

SIONNASDAQ·USD·Closed

$5.87

−3.14%

$5.87

−$0.19 (3.14%)

52W Range

4thpctl

Volume

0.57×avg

Mkt Cap

265.03MUSD

P/E

-2.7TTM

Div Yield

–ann

SION: Sionna Therapeutics, Inc. Stock Analysis | finqOS